- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Mankind Pharma Limited — Credit Ratings, 29-10-2025: Credit Rating
29-10-2025 | 06:06 pm
29-10-2025 | 06:06 pm
CRISIL Ratings has reaffirmed 'Crisil AA+/Stable' for Mankind Pharma's ₹400 Cr and ₹4,600 Cr Non-Convertible Debentures. Its 'Crisil A1+' rating for ₹1,500 Cr Commercial Paper (reduced from ₹5,000 Cr) was also reaffirmed. The 'Crisil AA+/Stable' rating for ₹1,250 Cr bank loan facilities has been withdrawn. This indicates a stable credit profile.
No comments yet. Be the first to comment!